C Barde Selected Research

efalizumab (Raptiva)

10/2006

Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Barde Research Topics

Disease

5	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2009 - 07/2006
2	Sarcoidosis (Schaumann Disease) 01/2011 - 01/2009
2	Crohn Disease (Crohn's Disease) 01/2011 - 01/2007
1	Opportunistic Infections (Opportunistic Infection) 07/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2011
1	Infections 07/2011
1	Granuloma 01/2011
1	Necrobiosis Lipoidica 01/2011
1	Pain (Aches) 01/2011
1	Skin Diseases (Skin Disease) 01/2011
1	Tuberculosis (Tuberculoses) 10/2009
1	Necrosis 10/2009
1	Deglutition Disorders (Dysphagia) 04/2009
1	Chronic Disease (Chronic Diseases) 01/2009
1	Acrodermatitis (Gianotti Crosti Syndrome) 01/2008
1	Spondylarthropathies 01/2007
1	Reactive Arthritis (Reiter Disease) 01/2007
1	Hidradenitis Suppurativa 11/2006

Drug/Important Bio-Agent (IBA)

5	Infliximab (Remicade)FDA Link 01/2011 - 10/2006
3	Adalimumab (Humira)FDA Link 10/2009 - 01/2007
2	Monoclonal AntibodiesIBA 01/2011 - 01/2009
2	Etanercept (Enbrel)FDA Link 01/2009 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009 - 01/2008
1	Interferon-gamma (Interferon, gamma)IBA 10/2009
1	Tuberculin (PPD)IBA 10/2009
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2009
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2009
1	Proteins (Proteins, Gene)FDA Link 01/2009
1	Leflunomide (Arava)FDA LinkGeneric 01/2007
1	Methotrexate (Mexate)FDA LinkGeneric 10/2006
1	efalizumab (Raptiva)FDA Link 10/2006

Therapy/Procedure

4	Therapeutics 01/2011 - 07/2006
1	Highly Active Antiretroviral Therapy (HAART) 07/2011
1	Intradermal Injections 01/2011
1	Aftercare (After-Treatment) 01/2011
1	Injections 01/2011
1	Intralesional Injections 01/2011
1	Biological Therapy 01/2008